Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
Enanta Pharmaceuticals (ENTA) Ownership - Who Owns Enanta Pharmaceuticals?
154 Followers
Enanta Pharmaceuticals (ENTA) Ownership Overview
37.25% Insiders
18.05% Mutual Funds
10.27% Other Institutional Investors
34.42% Public Companies and
Individual Investors
The ownership structure of Enanta Pharmaceuticals (ENTA) stock is a mix of institutional, retail and individual investors. Approximately 28.33% of the company’s stock is owned by Institutional Investors, 37.25% is owned by Insiders and 34.42% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 15, 2023 | Terry Vance Director | xxxxxxxxxxxxx | $139490 |
| Dec 06, 2023 | xxxxxxxxxxxxx | $5142 | |
| Dec 06, 2023 | Tara Lynn Kieffer Chief Product Strategy Officer | xxxxxxxxxxxxx | $20464 |
| Dec 06, 2023 | xxxxxxxxxxxxx | $23228 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $36578700 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,095,000 | Institution | 9.89% | 34,651,300 | |
| 1,069,099 | Institution | 5.05% | 17,682,897 | |
| 909,637 | Institution | 4.29% | 15,045,396 | |
| 810,609 | Insider | 3.83% | 13,407,473 | |
| 792,030 | Institution | 3.74% | 13,100,176 | |
| 442,040 | Institution | 2.09% | 7,311,342 | |
| 373,295 | Insider | 1.76% | 6,174,299 | |
| 216,818 | Institution | 1.02% | 3,586,170 | |
| 196,562 | Institution | 0.93% | 3,251,135 | |
| 192,575 | Institution | 0.91% | 3,185,191 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 909,637 | Institution | 4.29% | 15,045,396 | |
| 442,040 | Institution | 2.09% | 7,311,342 | |
| 216,818 | Institution | 1.02% | 3,586,170 | |
| 196,562 | Institution | 0.93% | 3,251,135 | |
| 192,575 | Institution | 0.91% | 3,185,191 | |
| 172,358 | Institution | 0.81% | 2,850,801 | |
| 166,553 | Institution | 0.79% | 2,754,787 | |
| 137,615 | Institution | 0.65% | 2,276,152 | |
| 119,191 | Institution | 0.56% | 1,971,419 | |
| 118,106 | Institution | 0.56% | 1,953,473 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 517,743 | Institution | 2.44% | 8,563,469 | |
| 629,597 | Institution | 2.97% | 7,851,075 | |
| 281,611 | Institution | 1.33% | 3,511,689 | |
| 186,254 | Institution | 0.88% | 3,080,641 | |
| 96,155 | Institution | 0.45% | 1,538,480 | |
| 36,202 | Institution | 0.17% | 940,890 | |
| 75,341 | Institution | 0.36% | 939,502 | |
| 67,322 | Institution | 0.32% | 839,505 | |
| 43,695 | Institution | 0.21% | 722,715 | |
| 43,243 | Institution | 0.20% | 715,239 |
FAQ
Who Owns Enanta Pharmaceuticals (ENTA)?
According to the latest TipRanks data, approximately 10.27% of the company's stock is held by institutional investors, 37.25% is held by insiders, and 34.42% is held by retail investors.
What percentage of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 10.27% of Enanta Pharmaceuticals (ENTA) stock is held by institutional investors.
What percentage of Enanta Pharmaceuticals (ENTA) stock is held by retail investors?
According to the latest TipRanks data, approximately 34.42% of Enanta Pharmaceuticals (ENTA) stock is held by retail investors.
Who owns the most shares of Enanta Pharmaceuticals (ENTA)?
Andrew J.M. Spokes owns the most shares of Enanta Pharmaceuticals (ENTA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.